Noa Eliakim‐Raz
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- Leonard LeiboviciMical PaulDafna YahavSalomon M. StemmerJihad BisharaAmos StemmerAnca Zalmanovici TrestioreanuAdi Lador
- Journals
- Cochrane Database of Systematic Reviews (8 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Clinical Microbiology and Infection (5 papers)Journal of Antimicrobial Chemotherapy (3 papers)BMJ Open (3 papers)
- Partner nations
- IsraelUnited KingdomSpain
In The Last Decade
Noa Eliakim‐Raz
68 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 115
- Applied Microbiology and Biotechnology 135
- Molecular Medicine 212
- Infectious Diseases 686
- Clinical Biochemistry 221
- Epidemiology 830
Countries citing papers authored by Noa Eliakim‐Raz
This map shows the geographic impact of Noa Eliakim‐Raz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Eliakim‐Raz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Eliakim‐Raz more than expected).
Fields of papers citing papers by Noa Eliakim‐Raz
This network shows the impact of papers produced by Noa Eliakim‐Raz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Eliakim‐Raz. The network helps show where Noa Eliakim‐Raz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noa Eliakim‐Raz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2019 | 10 | |
| 7 | 2019 | 36 | |
| 8 | Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study | 2018 | 2 |
| 9 | 2018 | 7 | |
| 10 | 2018 | 48 | |
| 11 | 2018 | 47 | |
| 12 | 2018 | 33 | |
| 13 | 2016 | 6 | |
| 14 | 2016 | 6 | |
| 15 | 2015 | 8 | |
| 16 | 2015 | 54 | |
| 17 | 2015 | 26 | |
| 18 | 2014 | 33 | |
| 19 | 2013 | 47 | |
| 20 | 2012 | 25 |
About Noa Eliakim‐Raz
Noa Eliakim‐Raz is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Infectious Diseases and Epidemiology, having authored 72 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (16 papers), Urinary Tract Infections Management (15 papers), COVID-19 Clinical Research Studies (13 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antibiotic Resistance in Bacteria (9 papers), Respiratory viral infections research (6 papers), Pneumonia and Respiratory Infections (6 papers) and Pediatric Urology and Nephrology Studies (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (135 citations), Molecular Medicine (212 citations), Infectious Diseases (686 citations), Clinical Biochemistry (221 citations) and Epidemiology (830 citations). Noa Eliakim‐Raz has collaborated with scholars based in Israel, United Kingdom and Spain. Frequent co-authors include Leonard Leibovici, Mical Paul, Dafna Yahav, Salomon M. Stemmer, Jihad Bishara, Amos Stemmer, Anca Zalmanovici Trestioreanu, Adi Lador, Anat Gafter‐Gvili and Elad Goldberg. Their work appears in journals such as Cochrane Database of Systematic Reviews, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.